Research ArticleHuman Studies
Diminished Glucose Transport and Phosphorylation in Alzheimer's Disease Determined by Dynamic FDG-PET
Morand Piert, Robert A. Koeppe, Bruno Giordani, Stanley Berent and David E. Kuhl
Journal of Nuclear Medicine February 1996, 37 (2) 201-208;
Morand Piert
Robert A. Koeppe
Bruno Giordani
Stanley Berent


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Diminished Glucose Transport and Phosphorylation in Alzheimer's Disease Determined by Dynamic FDG-PET
Morand Piert, Robert A. Koeppe, Bruno Giordani, Stanley Berent, David E. Kuhl
Journal of Nuclear Medicine Feb 1996, 37 (2) 201-208;
Jump to section
Related Articles
- No related articles found.
Cited By...
- The brains "dark energy" puzzle upgraded: [18F]FDG uptake, delivery and phosphorylation, and their coupling with resting-state brain activity
- Metabolic response of microglia to amyloid deposition during Alzheimers disease progression in a mouse model
- Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature
- Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons
- Rapid Scanning Protocol for Brain 18F-FDG PET: A Validation Study
- Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
- Increased Vulnerability of Brain Mitochondria in Diabetic (Goto-Kakizaki) Rats With Aging and Amyloid-{beta} Exposure
- Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats
- FDG PET Imaging in Patients with Pathologically Verified Dementia
- Amyloid {beta}-Peptide Impairs Glucose Transport in Hippocampal and Cortical Neurons: Involvement of Membrane Lipid Peroxidation
- Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats